IBDEI0Z7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16214,1,3,0)
 ;;=3^Personal Hx of PUD
 ;;^UTILITY(U,$J,358.3,16214,1,4,0)
 ;;=4^Z87.11
 ;;^UTILITY(U,$J,358.3,16214,2)
 ;;=^5063482
 ;;^UTILITY(U,$J,358.3,16215,0)
 ;;=D73.9^^88^843^70
 ;;^UTILITY(U,$J,358.3,16215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16215,1,3,0)
 ;;=3^Spleen Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16215,1,4,0)
 ;;=4^D73.9
 ;;^UTILITY(U,$J,358.3,16215,2)
 ;;=^5002386
 ;;^UTILITY(U,$J,358.3,16216,0)
 ;;=K26.7^^88^843^71
 ;;^UTILITY(U,$J,358.3,16216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16216,1,3,0)
 ;;=3^Ulcer,Chronic Duodenal w/o Hemorrhage/Perforation
 ;;^UTILITY(U,$J,358.3,16216,1,4,0)
 ;;=4^K26.7
 ;;^UTILITY(U,$J,358.3,16216,2)
 ;;=^5008526
 ;;^UTILITY(U,$J,358.3,16217,0)
 ;;=K25.7^^88^843^72
 ;;^UTILITY(U,$J,358.3,16217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16217,1,3,0)
 ;;=3^Ulcer,Chronic Gastric w/o Hemorrhage/Perforation
 ;;^UTILITY(U,$J,358.3,16217,1,4,0)
 ;;=4^K25.7
 ;;^UTILITY(U,$J,358.3,16217,2)
 ;;=^5008521
 ;;^UTILITY(U,$J,358.3,16218,0)
 ;;=K27.7^^88^843^73
 ;;^UTILITY(U,$J,358.3,16218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16218,1,3,0)
 ;;=3^Ulcer,Chronic Peptic w/o Hemorrhage/Perforation
 ;;^UTILITY(U,$J,358.3,16218,1,4,0)
 ;;=4^K27.7
 ;;^UTILITY(U,$J,358.3,16218,2)
 ;;=^5008535
 ;;^UTILITY(U,$J,358.3,16219,0)
 ;;=D55.9^^88^844^1
 ;;^UTILITY(U,$J,358.3,16219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16219,1,3,0)
 ;;=3^Anemia d/t Enzyme Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16219,1,4,0)
 ;;=4^D55.9
 ;;^UTILITY(U,$J,358.3,16219,2)
 ;;=^5002304
 ;;^UTILITY(U,$J,358.3,16220,0)
 ;;=D63.1^^88^844^2
 ;;^UTILITY(U,$J,358.3,16220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16220,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,16220,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,16220,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,16221,0)
 ;;=D63.0^^88^844^3
 ;;^UTILITY(U,$J,358.3,16221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16221,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,16221,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,16221,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16222,0)
 ;;=D63.8^^88^844^4
 ;;^UTILITY(U,$J,358.3,16222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16222,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16222,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,16222,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,16223,0)
 ;;=D59.9^^88^844^5
 ;;^UTILITY(U,$J,358.3,16223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16223,1,3,0)
 ;;=3^Anemia,Acquired Hemolytic,Unspec
 ;;^UTILITY(U,$J,358.3,16223,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,16223,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,16224,0)
 ;;=D62.^^88^844^6
 ;;^UTILITY(U,$J,358.3,16224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16224,1,3,0)
 ;;=3^Anemia,Acute Posthemorrhagic
 ;;^UTILITY(U,$J,358.3,16224,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,16224,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,16225,0)
 ;;=D61.9^^88^844^7
 ;;^UTILITY(U,$J,358.3,16225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16225,1,3,0)
 ;;=3^Anemia,Aplastic,Unspec
 ;;^UTILITY(U,$J,358.3,16225,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,16225,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,16226,0)
 ;;=D52.9^^88^844^8
 ;;^UTILITY(U,$J,358.3,16226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16226,1,3,0)
 ;;=3^Anemia,Folate Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,16226,1,4,0)
 ;;=4^D52.9
 ;;^UTILITY(U,$J,358.3,16226,2)
 ;;=^5002293
 ;;^UTILITY(U,$J,358.3,16227,0)
 ;;=D58.9^^88^844^9
 ;;^UTILITY(U,$J,358.3,16227,1,0)
 ;;=^358.31IA^4^2
